Literature DB >> 27230641

Vascular Complications of Diabetes.

Joshua A Beckman1, Mark A Creager2.   

Abstract

Over the last several decades, the global incidence and prevalence of diabetes mellitus has increased significantly. The raised incidence rate is projected to continue as greater numbers of persons adopt a Western lifestyle and diet. Patients with diabetes mellitus are at heightened risk of both adverse microvascular and cardiovascular events. Moreover, once cardiovascular disease develops, diabetes mellitus exacerbates progression and worsens outcomes. The medical management of patients with diabetes mellitus mandates comprehensive risk factor modification and antiplatelet therapy. Recent clinical trials of new medical therapies continue to inform the care of patients with diabetes mellitus to reduce both cardiovascular morbidity and mortality.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; cardiovascular disease; deep vein thrombosis; diabetes mellitus; risk factor

Mesh:

Year:  2016        PMID: 27230641     DOI: 10.1161/CIRCRESAHA.115.306884

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  85 in total

Review 1.  Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care.

Authors:  Ali Manouchehri; Elishama Kanu; Michael J Mauro; Aaron W Aday; Jonathan R Lindner; Javid Moslehi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-26       Impact factor: 8.311

Review 2.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

Review 3.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Microvascular Disease, Peripheral Artery Disease, and Amputation.

Authors:  Joshua A Beckman; Meredith S Duncan; Scott M Damrauer; Quinn S Wells; Joey V Barnett; David H Wasserman; Roger J Bedimo; Adeel A Butt; Vincent C Marconi; Jason J Sico; Hilary A Tindle; Marc P Bonaca; Aaron W Aday; Matthew S Freiberg
Journal:  Circulation       Date:  2019-07-08       Impact factor: 29.690

5.  Apigenin alleviates STZ-induced diabetic cardiomyopathy.

Authors:  Huang-Jun Liu; Yun-Lin Fan; Hai-Han Liao; Yuan Liu; Si Chen; Zhen-Guo Ma; Ning Zhang; Zheng Yang; Wei Deng; Qi-Zhu Tang
Journal:  Mol Cell Biochem       Date:  2017-02-07       Impact factor: 3.396

Review 6.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

7.  Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years.

Authors:  Tsung-Ying Lee; Shihchen Kuo; Chen-Yi Yang; Huang-Tz Ou
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

8.  Increased Drp1 Acetylation by Lipid Overload Induces Cardiomyocyte Death and Heart Dysfunction.

Authors:  Qingxun Hu; Huiliang Zhang; Nicolás Gutiérrez Cortés; Dan Wu; Pei Wang; Jing Zhang; Julie A Mattison; Eric Smith; Lisa F Bettcher; Mingyi Wang; Edward G Lakatta; Shey-Shing Sheu; Wang Wang
Journal:  Circ Res       Date:  2020-01-03       Impact factor: 17.367

9.  Improvement of cardiac ventricular function by magnesium treatment in chronic streptozotocin-induced diabetic rat heart.

Authors:  Hamida Aboalgasm; Morea Petersen; Asfree Gwanyanya
Journal:  Cardiovasc J Afr       Date:  2020-12-10       Impact factor: 1.167

10.  Nε-Carboxymethyl-Lysine Negatively Regulates Foam Cell Migration via the Vav1/Rac1 Pathway.

Authors:  Zhengyang Bao; Lili Zhang; Lihua Li; Jinchuan Yan; Qiwen Pang; Zhen Sun; Yue Geng; Lele Jing; Chen Shao; Zhongqun Wang
Journal:  J Immunol Res       Date:  2020-02-28       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.